706 related articles for article (PubMed ID: 9162525)
21. Identification of a soluble IL-2 receptor beta-chain from human lymphoid cell line cells.
Honda M; Kitamura K; Takeshita T; Sugamura K; Tokunaga T
J Immunol; 1990 Dec; 145(12):4131-5. PubMed ID: 2258611
[TBL] [Abstract][Full Text] [Related]
22. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
Symons JA; Wood NC; Di Giovine FS; Duff GW
J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
[TBL] [Abstract][Full Text] [Related]
23. [Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].
Setoyama Y; Imai J; Ishikawa T; Sakaida H; Takaori-Kondo A; Kawamata S; Uchiyama T
Rinsho Byori; 1994 Aug; 42(8):834-42. PubMed ID: 7933620
[TBL] [Abstract][Full Text] [Related]
24. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
[TBL] [Abstract][Full Text] [Related]
25. Non random activation of endogenous interleukin-2, (IL-2), IL-2 receptor alpha and IL-2 receptor beta genes after transfection of mouse fibroblasts with a cDNA for the alpha chain of the human IL-2 receptor.
Han D; Plaisance S; Rubinstein E; Alileche A; Pottin-Clemenceau C; Kim TS; Cohen EP; Jasmin C; Azzarone B
Eur J Immunol; 1995 Jul; 25(7):1905-12. PubMed ID: 7621867
[TBL] [Abstract][Full Text] [Related]
26. Endocytosis of the beta chain of interleukin-2 receptor requires neither interleukin-2 nor the gamma chain.
Hémar A; Lieb M; Subtil A; DiSanto JP; Dautry-Varsat A
Eur J Immunol; 1994 Sep; 24(9):1951-5. PubMed ID: 8088315
[TBL] [Abstract][Full Text] [Related]
27. The roles of serum IL-18, IL-10, TNF-alpha and sIL-2R in patients with chronic hepatitis C.
Jia HY; Du J; Zhu SH; Ma YJ; Chen HY; Yang BS; Cai HF
Hepatobiliary Pancreat Dis Int; 2002 Aug; 1(3):378-82. PubMed ID: 14607710
[TBL] [Abstract][Full Text] [Related]
28. Functional studies of soluble low-affinity interleukin-2 receptors in rheumatoid synovial fluid.
Miossec P; Elhamiani M; Edmonds-Alt X; Sany J; Hirn M
Arthritis Rheum; 1990 Nov; 33(11):1688-94. PubMed ID: 2242065
[TBL] [Abstract][Full Text] [Related]
29. Soluble interleukin-2R alpha test kits measure different epitopes: sIL-2R alpha test kits comparison with a newly developed inhouse sIL-2R alpha sandwich ELISA.
Kazim K; Wild G; Ward A
J Clin Lab Immunol; 1998; 50(2):55-61. PubMed ID: 10470623
[TBL] [Abstract][Full Text] [Related]
30. A correlation between acute phase proteins and cytokines in patients suffering from mycosis fungoides.
Pawlaczyk M; Sobieska M
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Sep; 15(3):107-12. PubMed ID: 17053844
[TBL] [Abstract][Full Text] [Related]
31. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms.
Bodey B; Psenko V; Lipsey AL; Kaiser HE
Anticancer Res; 1996; 16(1):219-24. PubMed ID: 8615612
[TBL] [Abstract][Full Text] [Related]
32. The role of tumor-associated macrophages on serum soluble IL-2R levels in B-cell lymphomas.
Sakai A; Yoshida N
J Clin Exp Hematop; 2014; 54(1):49-57. PubMed ID: 24942946
[TBL] [Abstract][Full Text] [Related]
33. In vivo production of type 1 cytokines in healthy sickle cell disease patients.
Taylor SC; Shacks SJ; Qu Z
J Natl Med Assoc; 1999 Nov; 91(11):619-24. PubMed ID: 10641497
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-2 fusion protein: an investigational therapy for interleukin-2 receptor expressing malignancies.
Nichols J; Foss F; Kuzel TM; LeMaistre CF; Platanias L; Ratain MJ; Rook A; Saleh M; Schwartz G
Eur J Cancer; 1997 Jan; 33 Suppl 1():S34-6. PubMed ID: 9166099
[TBL] [Abstract][Full Text] [Related]
35. Serum levels of interleukins 2, 6 and 8, soluble interleukin-2 receptor and intercellular adhesion molecule-1 during treatment with interleukin-2 plus interferon-alfa.
Vuoristo MS; Kellokumpu-Lehtinen P; Laine S; Soppi E
Immunopharmacol Immunotoxicol; 1996 Aug; 18(3):337-54. PubMed ID: 8872489
[TBL] [Abstract][Full Text] [Related]
36. Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis.
Takahashi S; Setoguchi Y; Nukiwa T; Kira S
Chest; 1991 Feb; 99(2):310-4. PubMed ID: 1989787
[TBL] [Abstract][Full Text] [Related]
37. Anti-soluble interleukin-2R alpha combinations measure different epitopes: comparison between different anti-sIL-2R alpha antibody combinations and a newly developed in-house sIL-2R alpha sandwich ELISA.
Kazim K; Wild G; Ward A
J Clin Lab Immunol; 1998; 50(1):17-25. PubMed ID: 10189613
[TBL] [Abstract][Full Text] [Related]
38. Soluble interleukin-2 receptor in stage I-III melanoma.
Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
[TBL] [Abstract][Full Text] [Related]
39. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
Evereklioglu C; Er H; Türköz Y; Cekmen M
Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
[TBL] [Abstract][Full Text] [Related]
40. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
